Cited by 255Liver Diseases and ImmunityGallbladder and Bile Duct DisordersPediatric Hepatobiliary Diseases and Treatments

Role of endoscopy in primary sclerosing cholangitis: European society of gastrointestinal endoscopy (ESGE) and European association for the study of the liver (EASL) clinical guideline

Open access
Aabakken, Lars, Karlsen, Tom, Albert, Jörg, Arvanitakis, Marianna, Chazouilleres, Olivier, Dumonceau, Jean-Marc, Färkkilä, Martti, Fickert, Peter +12 more·2017·Endoscopy

Abstract

MAIN RECOMMENDATIONS: 1 ESGE/EASL recommend that, as the primary diagnostic modality for PSC, magnetic resonance cholangiography (MRC) should be preferred over endoscopic retrograde cholangiopancreatography (ERCP). Moderate quality evidence, strong recommendation. 2 ESGE/EASL suggest that ERCP can be considered if MRC plus liver biopsy is equivocal or contraindicated in patients with persisting clinical suspicion of PSC. The risks of ERCP have to be weighed against the potential benefit with regard to surveillance and treatment recommendations. Low quality evidence, weak recommendation. 6 ESGE/EASL suggest that, in patients with an established diagnosis of PSC, MRC should be considered before therapeutic ERCP. Weak recommendation, low quality evidence. 7 ESGE/EASL suggest performing endoscopic treatment with concomitant ductal sampling (brush cytology, endobiliary biopsies) of suspected significant strictures identified at MRC in PSC patients who present with symptoms likely to improve following endoscopic treatment. Strong recommendation, low quality evidence. 9 ESGE/EASL recommend weighing the anticipated benefits of biliary papillotomy/sphincterotomy against its risks on a case-by-case basis. Strong recommendation, moderate quality evidence. Biliary papillotomy/sphincterotomy should be considered especially after difficult cannulation. Strong recommendation, low quality evidence. 16 ESGE/EASL suggest routine administration of prophylactic antibiotics before ERCP in patients with PSC. Strong recommendation, low quality evidence. 17 EASL/ESGE recommend that cholangiocarcinoma (CCA) should be suspected in any patient with worsening cholestasis, weight loss, raised serum CA19-9, and/or new or progressive dominant stricture, particularly with an associated enhancing mass lesion. Strong recommendation, moderate quality evidence. 19 ESGE/EASL recommend ductal sampling (brush cytology, endobiliary biopsies) as part of the initial investigation for the diagnosis and staging of suspected CCA in patients with PSC. Strong recommendation, high quality evidence.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1055/s-0043-107029

Cites

141 of 141 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. DeOliveira ML, Cunningham SC, Cameron JL et al. Cholangiocarcino- ma: thirty-one-year experience with 564 patients at a single institu- tion. Ann Surg 2007; 245: 755 -762

Cited by

Sorted by citations

Authors
Aabakken, L., Karlsen, T., Albert, J., Arvanitakis, M., Chazouilleres, O., Dumonceau, J.-M., Färkkilä, M., Fickert, P., Hirschfield, G., Laghi, A., Marzioni, M., Fernandez, M., Pereira, S., Pohl, J., Poley, J.-W., Ponsioen, C., Schramm, C., Swahn, F., Tringali, A., & Hassan, C.
Affiliations
  • University of Oslo (NO)
  • Oslo University Hospital (NO)
  • Robert Bosch Hospital (DE)
  • Université Libre de Bruxelles (BE)
  • Service d’Hépatologie, Hôpital Saint-Antoine, Assistance Publique – Hôpitaux de Paris, Centre de référence des maladies inflammatoires du foie et des voies biliaires, Filière Maladies Rares du Foie de l’Adulte et de l’Enfant (FILFOIE), UPMC UNIV Paris 06, France
  • Gastroenterología Diagnóstica Terapeútica (AR)
  • Helsinki University Hospital (FI)
  • Medical University of Graz (AT)
  • National Institute for Health and Care Research (GB)
  • Sapienza University of Rome (IT)
  • Marche Polytechnic University (IT)
  • Department of Gastroenterology, Hepatopancreatology and Digestive Oncology, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium
  • The Royal Free Hospital (GB)
  • Klinikum im Friedrichshain (DE)
  • Erasmus MC (NL)
  • Amsterdam UMC Location University of Amsterdam (NL)
  • University Medical Center Hamburg-Eppendorf (DE)
  • Karolinska University Hospital (SE)
  • Digestive Endoscopy Unit, Catholic University, Rome, Italy
  • Digestive Endoscopy Unit, Nuovo Regina Margherita Hospital, Rome, Italy
Venue
Endoscopy
Published
2017-04-18
Volume
49
Issue
06
Pages
588-608
ISSN
  • 0013-726X (ISSN-L)
  • 1438-8812
OpenAlex
W2607081164
Cited by
255
References
140
Citations by year
2026: 12 · 2025: 17 · 2024: 26 · 2023: 25 · 2022: 28 · 2021: 36 · 2020: 35 · 2019: 41 · 2018: 29 · 2017: 5
FWCI
18.59
Type
journal article
Language
en
Open access
Locations
  • Endoscopy (publishedVersion)
  • PubMed (publishedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
  • Pure Amsterdam UMC (submittedVersion, other-oa)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
  • Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
  • Zurich Open Repository and Archive (University of Zurich)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Gallbladder and Bile Duct Disorders
  • Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
Keywords
primary sclerosing cholangitis, endoscopic diagnosis, magnetic resonance cholangiography, endoscopic retrograde cholangiopancreatography, biliary strictures, brush cytology, sphincterotomy, antibiotic prophylaxis, cholangiocarcinoma, CA19-9, cholestasis
MeSH terms
Bile Duct Neoplasms, Biopsy, Cholangiography, Cholangiopancreatography, Endoscopic Retrograde, Humans, Magnetic Resonance Imaging, Cholangitis, Sclerosing, Sphincterotomy, Endoscopic, Cholangiocarcinoma

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review